The catalytic domain of protein kinase Cdelta confers protection from down-regulation induced by bryostatin 1 - PubMed (original) (raw)
. 1997 Dec 26;272(52):33338-43.
doi: 10.1074/jbc.272.52.33338.
Affiliations
- PMID: 9407126
- DOI: 10.1074/jbc.272.52.33338
Free article
The catalytic domain of protein kinase Cdelta confers protection from down-regulation induced by bryostatin 1
P S Lorenzo et al. J Biol Chem. 1997.
Free article
Abstract
Bryostatin 1 (Bryo) has been shown to induce biphasic dose-response curves for down-regulating protein kinase Cdelta (PKCdelta) as well as for protecting PKCdelta from down-regulation induced by phorbol 12-myristate 13-acetate (PMA). To identify regions within PKCdelta that confer these responses to Bryo, we utilized reciprocal PKCalpha and PKCdelta chimeras (PKCalpha/delta and PKCdelta/alpha) constructed by exchanging the regulatory and catalytic domains of these PKCs. These chimeras and wild-type PKCalpha/alpha and PKCdelta/delta constructed in the same way were stably expressed in NIH 3T3 fibroblasts. Twenty-four h of treatment with Bryo induced a biphasic dose-response curve for down-regulating both wild-type PKCdelta/delta and the PKCalpha/delta chimera. In contrast, Bryo led to a nearly complete down-regulation of both PKCalpha/alpha and PKCdelta/alpha and also produced a faster mobility form of these species on SDS-polyacrylamide gel electrophoresis. The nature of both the regulatory and, to a lesser extent, the catalytic domains affected the potency of Bryo to down-regulate the chimeric PKC proteins as well as to protect PKCalpha/delta and PKCdelta/delta from down-regulation. Bryo at high concentrations also inhibited the down-regulation of PKCdelta/delta and PKCalpha/delta induced by 1 microM PMA when co-applied. The portion of PKC protected by Bryo from down-regulation by either Bryo or PMA was localized in the particulate fraction of the cells. We conclude that the catalytic domain of PKCdelta confers protection from down-regulation induced by Bryo or Bryo plus PMA, suggesting that this domain contains the isotype-specific determinants involved in the unique effect of Bryo on PKCdelta.
Similar articles
- Differential roles of the tandem C1 domains of protein kinase C delta in the biphasic down-regulation induced by bryostatin 1.
Lorenzo PS, Bögi K, Hughes KM, Beheshti M, Bhattacharyya D, Garfield SH, Pettit GR, Blumberg PM. Lorenzo PS, et al. Cancer Res. 1999 Dec 15;59(24):6137-44. Cancer Res. 1999. PMID: 10626804 - Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
Szallasi Z, Denning MF, Smith CB, Dlugosz AA, Yuspa SH, Pettit GR, Blumberg PM. Szallasi Z, et al. Mol Pharmacol. 1994 Nov;46(5):840-50. Mol Pharmacol. 1994. PMID: 7969070 - Both the catalytic and regulatory domains of protein kinase C chimeras modulate the proliferative properties of NIH 3T3 cells.
Acs P, Wang QJ, Bögi K, Marquez AM, Lorenzo PS, Bíró T, Szállási Z, Mushinski JF, Blumberg PM. Acs P, et al. J Biol Chem. 1997 Nov 7;272(45):28793-9. doi: 10.1074/jbc.272.45.28793. J Biol Chem. 1997. PMID: 9353351 - Differentiation and growth modulation of myeloid leukemia cells by the protein kinase C activating agent bryostatin-1.
Steube KG, Drexler HG. Steube KG, et al. Leuk Lymphoma. 1993 Jan;9(1-2):141-8. doi: 10.3109/10428199309148517. Leuk Lymphoma. 1993. PMID: 8477194 Review. - Challenges to the development of bryostatin-type anticancer drugs based on the activation mechanism of protein kinase Cδ.
Irie K, Yanagita RC, Nakagawa Y. Irie K, et al. Med Res Rev. 2012 May;32(3):518-35. doi: 10.1002/med.20220. Epub 2010 Nov 9. Med Res Rev. 2012. PMID: 22539107 Review.
Cited by
- Biological activity of the bryostatin analog Merle 23 on mouse epidermal cells and mouse skin.
Kelsey JS, Cataisson C, Chen J, Herrmann MA, Petersen ME, Baumann DO, McGowan KM, Yuspa SH, Keck GE, Blumberg PM. Kelsey JS, et al. Mol Carcinog. 2016 Dec;55(12):2183-2195. doi: 10.1002/mc.22460. Epub 2016 Feb 9. Mol Carcinog. 2016. PMID: 26859836 Free PMC article. - Neristatin 1 provides critical insight into bryostatin 1 structure-function relationships.
Kedei N, Kraft MB, Keck GE, Herald CL, Melody N, Pettit GR, Blumberg PM. Kedei N, et al. J Nat Prod. 2015 Apr 24;78(4):896-900. doi: 10.1021/acs.jnatprod.5b00094. Epub 2015 Mar 26. J Nat Prod. 2015. PMID: 25808573 Free PMC article. - The synthetic bryostatin analog Merle 23 dissects distinct mechanisms of bryostatin activity in the LNCaP human prostate cancer cell line.
Kedei N, Telek A, Czap A, Lubart ES, Czifra G, Yang D, Chen J, Morrison T, Goldsmith PK, Lim L, Mannan P, Garfield SH, Kraft MB, Li W, Keck GE, Blumberg PM. Kedei N, et al. Biochem Pharmacol. 2011 Jun 1;81(11):1296-308. doi: 10.1016/j.bcp.2011.03.018. Epub 2011 Mar 30. Biochem Pharmacol. 2011. PMID: 21458422 Free PMC article. - Protein kinase C modulates inactivation of Kv3.3 channels.
Desai R, Kronengold J, Mei J, Forman SA, Kaczmarek LK. Desai R, et al. J Biol Chem. 2008 Aug 8;283(32):22283-94. doi: 10.1074/jbc.M801663200. Epub 2008 Jun 6. J Biol Chem. 2008. PMID: 18539595 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources